David Killock

1.2k total citations
211 papers, 879 citations indexed

About

David Killock is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David Killock has authored 211 papers receiving a total of 879 indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Oncology, 63 papers in Molecular Biology and 54 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David Killock's work include Cancer Immunotherapy and Biomarkers (26 papers), CAR-T cell therapy research (26 papers) and Chronic Lymphocytic Leukemia Research (18 papers). David Killock is often cited by papers focused on Cancer Immunotherapy and Biomarkers (26 papers), CAR-T cell therapy research (26 papers) and Chronic Lymphocytic Leukemia Research (18 papers). David Killock collaborates with scholars based in United States, United Kingdom and India. David Killock's co-authors include Aleksandar Ívetic, Maddy Parsons, Simon Ameer‐Beg, Marouan Zarrouk, Anne J. Ridley, Dorian O. Haskard, Marketa Zvelebil, Jessica E. Davies, Guillaume Charras and Justin Joachim and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Biochemical Journal.

In The Last Decade

David Killock

198 papers receiving 865 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Killock United States 13 345 344 214 151 146 211 879
Elisabetta Bandiera Italy 22 411 1.2× 345 1.0× 185 0.9× 142 0.9× 258 1.8× 32 1.4k
François Kuonen Switzerland 17 298 0.9× 287 0.8× 171 0.8× 80 0.5× 148 1.0× 42 712
Elisa Melucci Italy 18 421 1.2× 465 1.4× 144 0.7× 108 0.7× 244 1.7× 31 871
Julia V. Burnier Canada 21 592 1.7× 408 1.2× 174 0.8× 123 0.8× 318 2.2× 73 1.2k
Hyung‐Gyoon Kim United States 17 541 1.6× 405 1.2× 197 0.9× 134 0.9× 189 1.3× 33 1.0k
Catalin Mihalcioiu Canada 14 391 1.1× 422 1.2× 155 0.7× 156 1.0× 283 1.9× 38 1000
Wuhu Zhang China 14 320 0.9× 492 1.4× 176 0.8× 135 0.9× 181 1.2× 38 969
Rashna Madan United States 18 316 0.9× 368 1.1× 152 0.7× 119 0.8× 188 1.3× 65 869
Stephen L. Eck United States 21 591 1.7× 400 1.2× 283 1.3× 133 0.9× 114 0.8× 35 1.3k
Harvey H. Hensley United States 21 628 1.8× 305 0.9× 105 0.5× 211 1.4× 173 1.2× 41 1.2k

Countries citing papers authored by David Killock

Since Specialization
Citations

This map shows the geographic impact of David Killock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Killock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Killock more than expected).

Fields of papers citing papers by David Killock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Killock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Killock. The network helps show where David Killock may publish in the future.

Co-authorship network of co-authors of David Killock

This figure shows the co-authorship network connecting the top 25 collaborators of David Killock. A scholar is included among the top collaborators of David Killock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Killock. David Killock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Killock, David. (2024). NICHE-2 validates the efficacy of neoadjuvant ICIs in dMMR colon cancer. Nature Reviews Clinical Oncology. 21(9). 640–640. 1 indexed citations
2.
Killock, David. (2023). CAR T cells induce durable remission of neuroblastoma. Nature Reviews Clinical Oncology. 20(6). 354–354. 2 indexed citations
3.
Killock, David. (2023). Docetaxel-based CRT improves survival in cisplatin-ineligible patients. Nature Reviews Clinical Oncology. 20(4). 210–210. 1 indexed citations
4.
Killock, David. (2023). Irradiation of asymptomatic bone metastases improves outcomes. Nature Reviews Clinical Oncology. 20(12). 817–817. 3 indexed citations
5.
Killock, David. (2023). From the ESMO Congress 2023. Nature Reviews Clinical Oncology. 21(1). 3–3. 1 indexed citations
6.
Killock, David. (2023). Recurrent nasopharyngeal carcinoma: hyperfractionation of IMRT improves outcomes. Nature Reviews Clinical Oncology. 20(5). 283–283. 5 indexed citations
7.
Killock, David. (2023). New anti-angiogenic option for mCRC. Nature Reviews Clinical Oncology. 20(9). 579–579. 1 indexed citations
8.
Killock, David. (2023). CAR T cells show superiority over standard therapies for RRMM. Nature Reviews Clinical Oncology. 20(4). 210–210. 1 indexed citations
9.
Killock, David. (2022). Promising OS with oncolytic virotherapy. Nature Reviews Clinical Oncology. 19(10). 616–616. 1 indexed citations
10.
Davies, Jessica E., Karolina Rzeniewicz, Justin Joachim, et al.. (2021). L-selectin regulates human neutrophil transendothelial migration. Journal of Cell Science. 134(3). 27 indexed citations
11.
Killock, David. (2021). Early ICI uptake on PET predicts response. Nature Reviews Clinical Oncology. 19(1). 6–6. 1 indexed citations
12.
Killock, David. (2021). Abemaciclib crowned in monarchE. Nature Reviews Clinical Oncology. 19(1). 5–5. 1 indexed citations
13.
Killock, David. (2021). A new standard for mastocytosis. Nature Reviews Clinical Oncology. 19(2). 71–71. 3 indexed citations
14.
Killock, David. (2020). CAR T cells are active in Hodgkin lymphoma. Nature Reviews Clinical Oncology. 17(10). 592–592. 1 indexed citations
15.
Killock, David. (2020). From the ASCO20 Virtual meeting. Nature Reviews Clinical Oncology. 17(8). 449–449. 2 indexed citations
16.
Killock, David. (2019). Anti-BCMA CAR T cells for MM. Nature Reviews Clinical Oncology. 16(8). 465–465. 1 indexed citations
17.
Killock, David. (2019). Benefits of adding ADT to RT confirmed. Nature Reviews Clinical Oncology. 17(1). 7–7. 1 indexed citations
18.
Killock, David. (2019). BRAF+MEKi and ICI triplets show promise in melanoma. Nature Reviews Clinical Oncology. 16(9). 525–525. 3 indexed citations
19.
Killock, David. (2018). Insights into the risk of fatal AEs with ICIs. Nature Reviews Clinical Oncology. 15(11). 653–653.
20.
Killock, David. (2018). mCRC: sequencing in REVERCE. Nature Reviews Clinical Oncology. 16(2). 67–67.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elisabetta Bandiera Breakdown of academic impact, for papers by François Kuonen Breakdown of academic impact, for papers by Elisa Melucci Breakdown of academic impact, for papers by Julia V. Burnier Breakdown of academic impact, for papers by Hyung‐Gyoon Kim Breakdown of academic impact, for papers by Catalin Mihalcioiu Breakdown of academic impact, for papers by Wuhu Zhang Breakdown of academic impact, for papers by Rashna Madan Breakdown of academic impact, for papers by Stephen L. Eck Breakdown of academic impact, for papers by Harvey H. Hensley
Rankless by CCL
2026